UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Structure Property Relationships of Carboxylic Acid Isosteres

Journal of medicinal chemistry, 2016-04, Vol.59 (7), p.3183-3203

2016

Volltextzugriff (PDF)

Exogenous α-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells

Proceedings of the National Academy of Sciences - PNAS, 2009-11, Vol.106 (47), p.20051-20056

2009

Volltextzugriff (PDF)

Altered microtubule dynamics in neurodegenerative disease: Therapeutic potential of microtubule-stabilizing drugs

Neurobiology of disease, 2017-09, Vol.105, p.328-335

2017

Volltextzugriff (PDF)

GPRC6A null mice exhibit osteopenia, feminization and metabolic syndrome

PloS one, 2008-12, Vol.3 (12), p.e3858-e3858

2008

Volltextzugriff (PDF)

Microtubule Stabilizing Agents as Potential Treatment for Alzheimer’s Disease and Related Neurodegenerative Tauopathies

Journal of medicinal chemistry, 2012-11, Vol.55 (21), p.8979-8996

2012

Volltextzugriff (PDF)

Therapeutic strategies for the treatment of tauopathies: Hopes and challenges

Alzheimer's & dementia, 2016-10, Vol.12 (10), p.1051-1065

2016

Volltextzugriff (PDF)

Chronic stress exacerbates tau pathology, neurodegeneration, and cognitive performance through a corticotropin-releasing factor receptor-dependent mechanism in a transgenic mouse model of tauopathy

The Journal of neuroscience, 2011-10, Vol.31 (40), p.14436-14449

2011

Volltextzugriff (PDF)

Characterization of tau binding by gosuranemab

Neurobiology of disease, 2020-12, Vol.146 (C), p.105120, Article 105120

2020

Volltextzugriff (PDF)

Intracerebral injection of preformed synthetic tau fibrils initiates widespread tauopathy and neuronal loss in the brains of tau transgenic mice

Neurobiology of disease, 2015-01, Vol.73, p.83-95

2015

Volltextzugriff (PDF)

Epothilone D improves microtubule density, axonal integrity, and cognition in a transgenic mouse model of tauopathy

The Journal of neuroscience, 2010-10, Vol.30 (41), p.13861-13866

2010

Volltextzugriff (PDF)

Microtubule-stabilizing agents as potential therapeutics for neurodegenerative disease

Bioorganic & medicinal chemistry, 2014-09, Vol.22 (18), p.5040-5049

2014

Volltextzugriff (PDF)

Distinct characteristics of limbic-predominant age-related TDP-43 encephalopathy in Lewy body disease

Acta neuropathologica, 2022-01, Vol.143 (1), p.15-31

2022

Volltextzugriff (PDF)

Brain-Penetrant, Orally Bioavailable Microtubule-Stabilizing Small Molecules Are Potential Candidate Therapeutics for Alzheimer’s Disease and Related Tauopathies

Journal of medicinal chemistry, 2014-07, Vol.57 (14), p.6116-6127

2014

Volltextzugriff (PDF)

Characterization of novel conformation-selective α-synuclein antibodies as potential immunotherapeutic agents for Parkinson's disease

Neurobiology of disease, 2020-03, Vol.136, p.104712-104712, Article 104712

2020

Volltextzugriff (PDF)

Identification of a Novel Extracellular Cation-sensing G-protein-coupled Receptor

The Journal of biological chemistry, 2005-12, Vol.280 (48), p.40201-40209

2005

Volltextzugriff (PDF)

The characterization of microtubule-stabilizing drugs as possible therapeutic agents for Alzheimer's disease and related tauopathies

Pharmacological research, 2011-04, Vol.63 (4), p.341-351

2011

Volltextzugriff (PDF)

Conformation-selective tau monoclonal antibodies inhibit tau pathology in primary neurons and a mouse model of Alzheimer's disease

Molecular neurodegeneration, 2020-11, Vol.15 (1), p.64-64, Article 64

2020

Volltextzugriff (PDF)

Brain-penetrant microtubule-stabilizing compounds as potential therapeutic agents for tauopathies

Biochemical Society transactions, 2012-08, Vol.40 (4), p.661-666

2012

Volltextzugriff (PDF)

1,2,4-Triazolo[1,5-a]pyrimidines in drug design

European journal of medicinal chemistry, 2019-03, Vol.165, p.332-346

2019

Volltextzugriff (PDF)

Effects of microglial depletion and TREM2 deficiency on Aβ plaque burden and neuritic plaque tau pathology in 5XFAD mice

Acta neuropathologica communications, 2021-09, Vol.9 (1), p.150-19, Article 150

2021

Volltextzugriff (PDF)

A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model

Molecular neurodegeneration, 2018-11, Vol.13 (1), p.59-59, Article 59

2018

Volltextzugriff (PDF)

Amyloid-β plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation

Nature medicine, 2018-01, Vol.24 (1), p.29-38

2018

Volltextzugriff (PDF)

Identification of Aminothienopyridazine Inhibitors of Tau Assembly by Quantitative High-Throughput Screening

Biochemistry (Easton), 2009-08, Vol.48 (32), p.7732-7745

2009

Volltextzugriff (PDF)

Lewy Body-like α-Synuclein Aggregates Resist Degradation and Impair Macroautophagy

The Journal of biological chemistry, 2013-05, Vol.288 (21), p.15194-15210

2013

Volltextzugriff (PDF)

1 – 25 von 135

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(132)
Mit Volltextzugriff
(127)

Publikationsform

Artikel
(134)
Buchkapitel
(1)

Sprache

Englisch
(135)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Structure Property Relationships of Carboxylic Acid Isosteres

Exogenous α-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells

Altered microtubule dynamics in neurodegenerative disease: Therapeutic potential of microtubule-stabilizing drugs

GPRC6A null mice exhibit osteopenia, feminization and metabolic syndrome

Microtubule Stabilizing Agents as Potential Treatment for Alzheimer’s Disease and Related Neurodegenerative Tauopathies

Passive immunization with phospho-tau antibodies reduces tau pathology and functional deficits in two distinct mouse tauopathy models

Therapeutic strategies for the treatment of tauopathies: Hopes and challenges

Chronic stress exacerbates tau pathology, neurodegeneration, and cognitive performance through a corticotropin-releasing factor receptor-dependent mechanism in a transgenic mouse model of tauopathy

Characterization of tau binding by gosuranemab

Intracerebral injection of preformed synthetic tau fibrils initiates widespread tauopathy and neuronal loss in the brains of tau transgenic mice

Epothilone D improves microtubule density, axonal integrity, and cognition in a transgenic mouse model of tauopathy

Microtubule-stabilizing agents as potential therapeutics for neurodegenerative disease

Distinct characteristics of limbic-predominant age-related TDP-43 encephalopathy in Lewy body disease

Brain-Penetrant, Orally Bioavailable Microtubule-Stabilizing Small Molecules Are Potential Candidate Therapeutics for Alzheimer’s Disease and Related Tauopathies

Characterization of novel conformation-selective α-synuclein antibodies as potential immunotherapeutic agents for Parkinson's disease

Identification of a Novel Extracellular Cation-sensing G-protein-coupled Receptor

The characterization of microtubule-stabilizing drugs as possible therapeutic agents for Alzheimer's disease and related tauopathies

Conformation-selective tau monoclonal antibodies inhibit tau pathology in primary neurons and a mouse model of Alzheimer's disease

Brain-penetrant microtubule-stabilizing compounds as potential therapeutic agents for tauopathies

1,2,4-Triazolo[1,5-a]pyrimidines in drug design

Effects of microglial depletion and TREM2 deficiency on Aβ plaque burden and neuritic plaque tau pathology in 5XFAD mice

A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model

Amyloid-β plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation

Identification of Aminothienopyridazine Inhibitors of Tau Assembly by Quantitative High-Throughput Screening

Lewy Body-like α-Synuclein Aggregates Resist Degradation and Impair Macroautophagy

Suchergebnisse filtern